Gain Therapeutics, Inc.

NasdaqGM:GANX Stock Report

Market Cap: US$41.4m

Gain Therapeutics, Inc. Company Information

Gain Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Gain Therapeutics, Inc.
  • Ticker: GANX
  • Exchange: NasdaqGM
  • Founded: 2017
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$41.367m
  • Shares Outstanding: 25.54m
  • Website: https://www.gaintherapeutics.com

Number of Employees


Location

  • Gain Therapeutics, Inc.
  • 4800 Montgomery Lane
  • Suite 220
  • Bethesda
  • Maryland
  • 20814
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GANXNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDMar 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 09:13
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.